Last reviewed · How we verify
Standard of care diuretic therapy — Competitive Intelligence Brief
marketed
Diuretic (mixed class standard of care)
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Standard of care diuretic therapy (Standard of care diuretic therapy) — University of Calgary. Standard diuretic therapy reduces fluid volume in the body by increasing urinary sodium and water excretion, thereby lowering blood pressure and reducing fluid overload.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Standard of care diuretic therapy TARGET | Standard of care diuretic therapy | University of Calgary | marketed | Diuretic (mixed class standard of care) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Diuretic (mixed class standard of care) class)
- University of Calgary · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Standard of care diuretic therapy CI watch — RSS
- Standard of care diuretic therapy CI watch — Atom
- Standard of care diuretic therapy CI watch — JSON
- Standard of care diuretic therapy alone — RSS
- Whole Diuretic (mixed class standard of care) class — RSS
Cite this brief
Drug Landscape (2026). Standard of care diuretic therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-of-care-diuretic-therapy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab